Guest blog by Helen Disney, Chief Executive and Founder of the Stockholm Network, a pan-European think tank.
When most of us look at taking a new medicine we tend to think it will make us better. Some of us may think about possible side effects but few of us expect the medicines we take to actually [...]
Posted in Biotech, Emerging Markets, Europe, Global, Guest Blog, Regulatory, Safety | Also tagged biosimilars, Brazil, China, counterfeit medicines, Emerging Markets, Europe, Indian, Regulatory, substandard medicines, Turkey, US
PharmExec Blog
Follow Us
RSS
Bookstore
US and Europe At Risk from Substandard Medicines